WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD
Taking everything into account, WELL scores 3 out of 10 in our fundamental rating. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. WELL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year WELL has reported negative net income.
In the past year WELL had a positive cash flow from operations.
In multiple years WELL reported negative net income over the last 5 years.
Of the past 5 years WELL 4 years had a positive operating cash flow.
1.2 Ratios
WELL has a Return On Assets (-1.60%) which is comparable to the rest of the industry.
With a Return On Equity value of -3.48%, WELL perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 38.51%, WELL is in line with its industry, outperforming 53.33% of the companies in the same industry.
In the last couple of years the Gross Margin of WELL has grown nicely.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WELL has been increased compared to 1 year ago.
The number of shares outstanding for WELL has been increased compared to 5 years ago.
WELL has a better debt/assets ratio than last year.
2.2 Solvency
WELL has an Altman-Z score of 0.99. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of WELL (0.99) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.59 indicates that WELL is somewhat dependend on debt financing.
WELL has a Debt to Equity ratio of 0.59. This is in the better half of the industry: WELL outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.99 |
ROIC/WACCN/A
WACC7.66%
2.3 Liquidity
WELL has a Current Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WELL (0.92) is better than 66.67% of its industry peers.
WELL has a Quick Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.92, WELL is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
WELL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.19%.
WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.78% yearly.
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
3.2 Future
Based on estimates for the next years, WELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.88% on average per year.
The Revenue is expected to grow by 15.85% on average over the next years. This is quite good.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.88%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 14.86 indicates a correct valuation of WELL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL indicates a rather cheap valuation: WELL is cheaper than 93.33% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.27. WELL is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.86 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as WELL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.77 |
4.3 Compensation for Growth
WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WELL's earnings are expected to grow with 30.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%
5. Dividend
5.1 Amount
No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (6/23/2025, 7:00:00 PM)
3.79
-0.03 (-0.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap959.10M
Analysts81
Price Target7.78 (105.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-661.05%
Min EPS beat(2)-1116.23%
Max EPS beat(2)-205.87%
EPS beat(4)1
Avg EPS beat(4)4130.26%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1642.24%
EPS beat(12)3
Avg EPS beat(12)973.71%
EPS beat(16)3
Avg EPS beat(16)622.27%
Revenue beat(2)1
Avg Revenue beat(2)-5.51%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.92%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.27%
PT rev (1m)-0.23%
PT rev (3m)-12.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)36.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)24.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)21.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.86 | ||
| P/S | 0.98 | ||
| P/FCF | N/A | ||
| P/OCF | 76.8 | ||
| P/B | 1.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.77 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY6.73%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY1.3%
SpS3.88
BVpS3.3
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score3
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.42 | ||
| Cap/Depr | 26.64% | ||
| Cap/Sales | 2.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 28.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 0.99 |
F-Score3
WACC7.66%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.88%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%
EBIT growth 1Y-191.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.91%
FCF growth 1Y-110.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.54%
OCF growth 3Y-22.85%
OCF growth 5YN/A